301 related articles for article (PubMed ID: 33441136)
41. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
42. A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach.
Tan MS; Cheah PL; Chin AV; Looi LM; Chang SW
Comput Biol Med; 2021 Dec; 139():104947. PubMed ID: 34678481
[TBL] [Abstract][Full Text] [Related]
43. Network reconstruction for trans acting genetic loci using multi-omics data and prior information.
Hawe JS; Saha A; Waldenberger M; Kunze S; Wahl S; Müller-Nurasyid M; Prokisch H; Grallert H; Herder C; Peters A; Strauch K; Theis FJ; Gieger C; Chambers J; Battle A; Heinig M
Genome Med; 2022 Nov; 14(1):125. PubMed ID: 36344995
[TBL] [Abstract][Full Text] [Related]
44. Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort.
Cong W; Meng X; Li J; Zhang Q; Chen F; Liu W; Wang Y; Cheng S; Yao X; Yan J; Kim S; Saykin AJ; Liang H; Shen L;
BMC Genomics; 2017 May; 18(1):421. PubMed ID: 28558704
[TBL] [Abstract][Full Text] [Related]
45. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
Front Immunol; 2018; 9():2727. PubMed ID: 30631320
[TBL] [Abstract][Full Text] [Related]
46. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.
Clark C; Dayon L; Masoodi M; Bowman GL; Popp J
Alzheimers Res Ther; 2021 Apr; 13(1):71. PubMed ID: 33794997
[TBL] [Abstract][Full Text] [Related]
47. Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.
Bihlmeyer NA; Merrill E; Lambert Y; Srivastava GP; Clark TW; Hyman BT; Das S
Alzheimers Dement; 2019 Jun; 15(6):788-798. PubMed ID: 30935898
[TBL] [Abstract][Full Text] [Related]
48. Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks.
Castrillo JI; Oliver SG
Methods Mol Biol; 2016; 1303():3-48. PubMed ID: 26235058
[TBL] [Abstract][Full Text] [Related]
49. Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts.
Li J; Zhu X; Chen JY
PLoS Comput Biol; 2009 Jul; 5(7):e1000450. PubMed ID: 19649302
[TBL] [Abstract][Full Text] [Related]
50. Systems biology and gene networks in Alzheimer's disease.
Wang ZT; Tan CC; Tan L; Yu JT
Neurosci Biobehav Rev; 2019 Jan; 96():31-44. PubMed ID: 30465785
[TBL] [Abstract][Full Text] [Related]
51. Alzheimer's Disease: Genomics and Beyond.
Song F; Han G; Bai Z; Peng X; Wang J; Lei H
Int Rev Neurobiol; 2015; 121():1-24. PubMed ID: 26315760
[TBL] [Abstract][Full Text] [Related]
52. Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.
Talwar P; Silla Y; Grover S; Gupta M; Agarwal R; Kushwaha S; Kukreti R
BMC Genomics; 2014 Mar; 15(1):199. PubMed ID: 24628925
[TBL] [Abstract][Full Text] [Related]
53. An overview of technologies for MS-based proteomics-centric multi-omics.
Rajczewski AT; Jagtap PD; Griffin TJ
Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
[TBL] [Abstract][Full Text] [Related]
54. Systems pharmacology approach uncovers the therapeutic mechanism of medicarpin against scopolamine-induced memory loss.
Li D; Cai C; Liao Y; Wu Q; Ke H; Guo P; Wang Q; Ding B; Fang J; Fang S
Phytomedicine; 2021 Oct; 91():153662. PubMed ID: 34333326
[TBL] [Abstract][Full Text] [Related]
55. Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease.
Morabito S; Miyoshi E; Michael N; Swarup V
Hum Mol Genet; 2020 Oct; 29(17):2899-2919. PubMed ID: 32803238
[TBL] [Abstract][Full Text] [Related]
56. Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease.
Xie L; Raj Y; Varathan P; He B; Yu M; Nho K; Salama P; Saykin AJ; Yan J
J Alzheimers Dis; 2024; 99(2):715-727. PubMed ID: 38728189
[TBL] [Abstract][Full Text] [Related]
57. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine.
Turanli B; Karagoz K; Gulfidan G; Sinha R; Mardinoglu A; Arga KY
Curr Pharm Des; 2018; 24(32):3778-3790. PubMed ID: 30398107
[TBL] [Abstract][Full Text] [Related]
58. Mapping the gene network landscape of Alzheimer's disease through integrating genomics and transcriptomics.
Rosenthal SB; Wang H; Shi D; Liu C; Abagyan R; McEvoy LK; Chen CH
PLoS Comput Biol; 2022 Feb; 18(2):e1009903. PubMed ID: 35213535
[TBL] [Abstract][Full Text] [Related]
59. Multi-Omics-Based Autophagy-Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology.
Park JC; Barahona-Torres N; Jang SY; Mok KY; Kim HJ; Han SH; Cho KH; Zhou X; Fu AKY; Ip NY; Seo J; Choi M; Jeong H; Hwang D; Lee DY; Byun MS; Yi D; Han JW; Mook-Jung I; Hardy J
Adv Sci (Weinh); 2022 Aug; 9(23):e2201212. PubMed ID: 35694866
[TBL] [Abstract][Full Text] [Related]
60. Identifying candidate genes and drug targets for Alzheimer's disease by an integrative network approach using genetic and brain region-specific proteomic data.
Liu A; Manuel AM; Dai Y; Fernandes BS; Enduru N; Jia P; Zhao Z
Hum Mol Genet; 2022 Sep; 31(19):3341-3354. PubMed ID: 35640139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
